Metastatic Breast Cancer

News

FDA approves new indications for pembrolizumab

Author:

Damian McNamara

Publish date: July 1, 2020

The FDA has approved pembrolizumab to treat cutaneous squamous cell carcinoma and unresectable or metastatic...

• Read More

News

Novel SERD, LSZ102, shows promise for pretreated ER+ breast cancer

Author:

Sharon Worcester

Publish date: June 30, 2020

LSZ102 was relatively well tolerated as a single agent and in combination with ribociclib and alperisib.

• Read More

News

FDA approves in-home breast cancer treatment

Author:

Nick Mulcahy

Publish date: June 30, 2020

The FDA approved a combination of pertuzumab, trastuzumab, and hyaluronidase – administered subcutaneously – for...

• Read More

Article

Key Studies in Metastatic Breast Cancer From ASCO 2020

Author:

Harold J. Burstein

Phd

Publish date: June 22, 2020

Key studies in metastatic breast cancer from ASCO 2020 focus on first-line checkpoint inhibition in TNBC; also, updated...

• Read More

Article

‘A good and peaceful death’: Cancer hospice during the pandemic

Author:

Kate Johnson

Publish date: June 5, 2020

COVID-19 may have prompted an increase in hospice care for cancer patients, nurses say.

• Read More

News

TILs and PET-CT can predict pCR in HER2-positive metastatic breast cancer

Author:

Alan P. Lyss, MD

Publish date: June 2, 2020

Updated results from PREDIX-HER2 have revealed useful research tools, but the findings probably won’t affect...

• Read More

News

Treating primary tumor doesn’t improve OS in stage IV breast cancer

Author:

Neil Osterweil

Publish date: June 1, 2020

Treating an intact primary tumor did not improve overall survival in women with de novo metastatic breast cancer...

• Read More

News

Pyrotinib bests lapatinib in HER2+ metastatic breast cancer

Author:

Andrew D. Bowser

Publish date: May 31, 2020

Patients who received pyrotinib had longer progression-free survival but a higher rate of grade 3 diarrhea.

• Read More

News

Expanding the role of PARP inhibitors in breast cancer

Author:

Will Pass

Publish date: May 31, 2020

Adding veliparib to chemotherapy improved survival in patients with BRCA-like breast cancer, particularly those...

• Read More

News

Tucatinib improves PFS, OS in HER2+ breast cancer with brain metastases

Author:

M. Alexander Otto

Publish date: May 30, 2020

Adding tucatinib to trastuzumab and capecitabine decreased the risk of death by 42% in HER2-positive breast...

• Read More

Pages

• « first
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• last »